Vaxcyte Inc. Common Stock vs Teradata Corporation Common Stock — how do they compare? Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B), while Teradata Corporation Common Stock trades at $29.6 (market cap $2.83B). The key difference: Vaxcyte Inc. Common Stock is far larger — about 3.7× Teradata Corporation Common Stock's market cap, and Vaxcyte Inc. Common Stock is trading nearer its 52-week high, Teradata Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and Teradata Corporation Common Stock for 0 Days on average.
| PCVX | TDC | |
|---|---|---|
Market Cap | $10.51B | $2.83B |
Volume | 2,644,694 | 1,343,944 |
Sector | Health | Technology |
52-Week High | $73.82 | $37.88 |
52-Week Low | $40.32 | $20.71 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $9.14B | $2.52B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →Teradata Corporation develops a hybrid cloud analytics and data platform, including its Teradata Vantage and VantageCloud products, that helps enterprises manage and analyze data across cloud, on-premises, and hybrid environments. It serves industries including retail, financial services, healthcare, and manufacturing.
Read more on TDC →